JEWISH KING JESUS IS COMING AT THE RAPTURE FOR US IN THE CLOUDS-DON'T MISS IT FOR THE WORLD.THE BIBLE TAKEN LITERALLY- WHEN THE PLAIN SENSE MAKES GOOD SENSE-SEEK NO OTHER SENSE-LEST YOU END UP IN NONSENSE.GET SAVED NOW- CALL ON JESUS TODAY.THE ONLY SAVIOR OF THE WHOLE EARTH - NO OTHER. 1 COR 15:23-JESUS THE FIRST FRUITS-CHRISTIANS RAPTURED TO JESUS-FIRST FRUITS OF THE SPIRIT-23 But every man in his own order: Christ the firstfruits; afterward they that are Christ’s at his coming.ROMANS 8:23 And not only they, but ourselves also, which have the firstfruits of the Spirit, even we ourselves groan within ourselves, waiting for the adoption, to wit, the redemption of our body.(THE PRE-TRIB RAPTURE)
DEATHS OR LIFE INJURIES FROM THESE SCAM VACCINE PFIZAR AND MODERNA
VACCINES STARTED IN CANADA DEC 15,20
FIRST THE CBC FINALLY ADMITS THE STATISTICS ABOUT COVID-19 ARE NOT THE RIGHT STATISTICS. THE REGION PLAYS WITH THE STATS. LIKE I SAID BEFORE. THEY PROBABLY ADD EVERY ONE WITH A COLD IN THE COVID CASES. PROBABLY EVERY DEATH THAT OCCURS. THEY ADD IT TO THE COVID DEATHS.THIS IS ALL JUST A SCAM TO CONTROL ALL OF US. AND TO KILL OR MAMINED US BELIEVING SHEEPLE. SO THE GOVERNMENTS OF THE WORLD CAN BE OUR SAVIORS. BY BRINGING ABOUT A WORLD GOVERNMENT. AND MY SISTER TOLD ME YESTERDAY. THAT THE VACCINES HAVE SOME THING IN THEM FROM ABORTED-MURDERED BABIES.IT APPEARS PFIZER AND MODERNA DO NOT USE ABORTED BABY PARTS IN THEIR VACCINE.I STILLWON'T BE TAKING IT. AND AT LEAST ONE PERSON HAD AN ALERGIC ATTACK FROM THE PFIZER VACCINE. PREGNANT WOMEN ARE WARNED NOT TO TAKE IT. IF THE LIBERAL WOMEN THINK THEY CAN HELP PEOPLE BY ABORTING-MURDERING BABIES FOR THE VACCINES THEY SURELY WILL. YOU CASN COUNT ON AND TAKE THAT TO THE BANK.
Several COVID-19 Vaccines Are Made Using Aborted Fetal Cells-December 15, 2020 Randolph Jason
In addition to standard concerns over the safety of COVID-19 vaccines is the moral dilemma of taking vaccines made with aborted fetal cells. For many, this alone is a cause for objection. Several of the vaccine candidates, including AstraZeneca’s COVID-19 vaccine, are made using aborted fetal cell lines.1,2-Several fact checkers — including Politifact,3 The Associated Press4 and Snopes5 — have labeled the claim as “false,” but is it? As it turns out, fact checkers are relying on semantics to “debunk” this claim. In reality, most thinking individuals are able to determine the truth of the matter once the details are explained.
Semantics and Technicalities Used to ‘Debunk’ the Truth-A common mistake by less experienced citizen journalists is to use rather general terms, assuming people will “get the gist” without having to be overly specific, and this is precisely what self-declared fact checkers home in on when rating something false or misleading.Fact checkers routinely rely on semantics and technicalities to break apart a given claim, and unless you carefully read their explanation, you’re likely to miss this and simply write it off based on the headline claiming something to be false. The case of COVID-19 vaccines containing aborted fetal cells is a perfect example of this, so let’s go through some of what you need to know before discounting this claim off-hand.Commonly Used Fetal Cell Lines-There are several cell lines commonly used in vaccine development that originate from aborted fetuses, including:-HEK2937,8,9,10,11 — human embryonic cell line originally derived from kidney tissue obtained from a female fetus aborted in the Netherlands in 1972-MRC512 — human embryonic cell line originally derived from the lung tissue of a 14-week-old male fetus aborted in 1966.PER.C613 — human embryonic cell line originally derived from the retina of an 18-week-old male fetus aborted in the Netherlands in 1985. WI3814 — human embryonic cell line originally derived from the lung tissue of a 12-week-old female fetus aborted in 1961. Vaccine makers using at least one of these fetal cell lines in the development of their COVID-19 vaccines include:15,16,17-AstraZeneca (HEK293)-Jansen Research and Development (owned by Johnson & Johnson), (PER.C6)-CanSino Biologics (HEK293)-University of Pittsburgh (HEK293)-ImmunityBio (HEK293)-Altimmune (PER.C6)-Vaccine makers using either “ethically derived” cell lines, meaning cell lines that do not originate from aborted human fetuses, or no cell lines at all, include Moderna, Merck, Novavax, Sanofi Pasteur, Pfizer, Inovio Pharmaceuticals, GlaxoSmithKline and Sinovac.18
Global News-What’s in Pfizer’s vaccine? A look at the ingredients-Rachael D'AmoreDEC 17,20
The newness of the novel coronavirus coupled with the quick development of a vaccine has put Pfizer and BioNTech's shots under the proverbial microscope — particularly about the ingredients it uses.a hand holding a bottle: LONDON, UNITED KINGDOM - DECEMBER 14: A dose of the Pfizer/BioNtech covid-19 vaccine at the Hurley Clinic in London, as hundreds of Covid-19 vaccination centres run by local doctors begin opening across England, on December 14, 2020 in London, England. GP practices in more than 100 locations will have the vaccine delivered to them on Monday, with some opening their clinics later in the afternoon. (Photo by Aaron Chown - WPA Pool/Getty Images) © Provided by Global News LONDON, UNITED KINGDOM - DECEMBER 14: A dose of the Pfizer/BioNtech covid-19 vaccine at the Hurley Clinic in London, as hundreds of Covid-19 vaccination centres run by local doctors begin opening across England, on December 14, 2020 in London, England. GP practices in more than 100 locations will have the vaccine delivered to them on Monday, with some opening their clinics later in the afternoon. (Photo by Aaron Chown - WPA Pool/Getty Images)-While there's no question this happened at warp speed, experts agree the listed ingredients are pretty standard.In fact, they're "almost simpler and more straightforward than any other vaccine," according to Kyle Anderson, an assistant professor of biochemistry, microbiology and immunology at the University of Saskatchewan."That's because it's a revolution in vaccine making," he said. "There's nothing in this vaccine that rings any alarm bells."Pfizer's vaccine was approved by Health Canada on Dec. 9. Canadians across the country have rolled up their sleeves this week to be among the first to receive the shot, which touts a 95 per cent effectiveness rate and no serious side effects.Its ingredients might look complicated, said Anderson, but they can be easily organized into four basic categories:Active ingredient-30 mcg of a nucleosidemodified messenger RNA (modRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2.This is the only active ingredient in the vaccine.U.K. advises people with serious allergies to avoid Pfizer-BioNTech’s COVID-19 vaccine-The mRNA — messenger RNA technology — sends tiny snippets of genetic code to cells, telling them to build proteins. In this case, it triggers the immune system to produce protective antibodies without using actual bits of the virus. "Old-fashioned" types of vaccines, required scientists having to express it in cells or chicken eggs to get the proteins right, Anderson said."And then we had to do all this clean-up," he said. "If we had problems with cleaning and purifying it, we could get adverse reactions or add things like mercury compounds to stabilize that. ... These are completely avoided with these mRNA-based vaccines."The mRNA-based vaccines may have more science behind them, but they're more efficient, Anderson said."Essentially, the message is telling your body how to make this one virus protein, and how to recognize it," he said.From there, the other ingredients form a "bubble" around the message, Anderson said, helping it become stable enough to get where it needs to go.Fats-lipids (0.43 mg (4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 0.05 mg 2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 0.09 mg 1,2-distearoyl-sn-glycero-3- phosphocholine, and 0.2 mg cholesterol)-The lipid molecule in Pfizer's vaccine contains four components."Each is necessary for the mRNA — the medicinal ingredient — to gain entry into cells and be expressed," said Roderick Slavcev, a professor at the University of Waterloo's School of Pharmacy. Slavcev and a team are currently developing a DNA-based vaccine.The molecule essentially protects the mRNA. Without it, the vital active ingredient could be broken down before getting that genetic code to the cell.This connection of fat is particularly delicate, experts say, which is why the Pfizer vaccine requires a subzero temperature for storage.Of all the ingredients, it's the lipids that have been misunderstood, Anderson believes.This is, in part, due to two vaccine recipients in the U.K. experiencing an adverse allergic reaction. It's been suggested that the reactions may have been caused by polyethylene glycol, or PEG, which helps stabilize the shot and is used in some other vaccines.But the ingredient is already widely used, Slavcevs said, and there is no reason to be concerned.PEG is found in a range of pharmaceutical, cosmetic and food products. It is also safely used at higher concentrations as a laxative. Slavcev said there have been some minor side effects recorded with PEG, but they're often as a result of taking high concentrations.The 0.05 mg of PEG in Pfizer's vaccine is "such a small quantity," Anderson said."It's like the carrier of the message. It's the envelope that your letter came in, and then you recycle the paper," he continued."If you eat, say, a steak, you're getting a lot of these fats and in far higher quantities, but they're digested and you just don't think about it."Lipids might also have a bad rap because "they have such long, complicated, really unpronounceable names," he added."It kind of reads like a shampoo bottle," he said with a laugh."All these Xs and Ys and Zs and numbers, it looks like an alien language. And it is to most of us. But it's just essentially a fat droplet."Salts-0.01 mg potassium chloride-0.01 mg monobasic potassium phosphate-0.36 mg sodium chloride-0.07 mg dibasic sodium phosphate dihydrate-Salts, like fats, are nothing new to vaccines, the experts agree. They're there for two reasons — to balance and to stabilize.Having salt components allows cells to retain their proper shape, Anderson said."If you get an IV at the hospital, there are salts and sugars in there. It makes your cells a little happier. They're there to help balance it out," he said.Components like potassium phosphate and dibasic sodium phosphate are there to make sure the pH — the acidity of a solution — is stable.They're actually variants of salt natural to the body that keep the pH balanced, Anderson said. The combination of these particular salts helps the body absorb the solution while also protecting the fat molecule and mRNA."It's going to last longer from the time of thawing it to injecting it in you," he explained."If there happened to be something slightly acidic in the syringe being using, that could destroy the vaccine. So this is really a protective measure that pH is going to be balanced across the time it actually reaches your cells.Sugar-6 mg sucrose-The sugar-water mixture is there to protect and to stabilize the vaccine during freezing.Pfizer's vaccine needs to be stored at an ultracold -70 C. The sugar helps keep things stable under this temperature, the experts said.It is, again, another common addition to a vaccine and other drug and pharmaceutical products."We're more likely to not trust something that we haven't seen or heard of before," Anderson said."Sucrose, we know it's sugar. But we don't necessarily think about all these fats in our body that have these complicated names, and there are hundreds more with complicated names."-Sign of the times-Ultimately, there's nothing in that ingredient list that is questionable or unnecessary, Slavcev said."Potentials for allergic responses or other adverse responses are always possible. It's impossible to predict how every human will react," he said, adding that all adverse reactions are and will continue to be documented.As for the speed of the vaccine's development? Get used to it."This is the future of vaccines," Anderson said."There comes a time in the complexity of how things are made — whether it's a computer program, a car, a drug, food — where you need to trust that there are experts who are critical enough to inspect this and ensure safety."He added: "This is one of the most scrutinized vaccines ever made. It hasn't been rushed, but there has been no delay."-- with files from the Associated Press and Reuters
USA TODAY-Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases.Karen Weintraub, USA TODAY 11/23/2020
The success of two COVID-19 candidate vaccines marks a turning point in the long history of vaccines and could lead to major advances against a variety of diseases.Vaccines developed by Pfizer/BioNTech and Moderna are more than 95% effective against COVID-19, trials show. Both depend on a technology never before used in a commercial vaccine that could upend the way future ones are made.This new messenger RNA technology, as well another method that depends on viruses to deliver vaccines, are transforming the field, said Brendan Wren, a professor of vaccinology at the London School of Hygiene and Tropical Medicine.
a laptop computer sitting on top of a table: Pfizer's COVID-19 vaccine is being shipped in specially designed, insulated containers that hold between 195 and 975 five-dose vials and are about the size of a carry-on suitcase. The vials are stored in flat, pizza box-sized compartments, each of which holds 195 vials. A fully-loaded thermal container, which is reusable, contains five of these and weighs about 70 pounds. These "shippers" as Pfizer calls them have space at the top for dry ice, which can keep the vaccine at the necessary temperature for ten days if unopened, or five days as long as it’s opened no more than twice a day for very short periods of time © Pfizer Inc. Pfizer's COVID-19 vaccine is being shipped in specially designed, insulated containers that hold between 195 and 975 five-dose vials and are about the size of a carry-on suitcase. The vials are stored in flat, pizza box-sized compartments, each of which holds 195 vials. A fully-loaded thermal container, which is reusable, contains five of these and weighs about 70 pounds. These "shippers" as Pfizer calls them have space at the top for dry ice, which can keep the vaccine at the necessary temperature for ten days if unopened, or five days as long as it’s opened no more than twice a day for very short periods of timeIt could be quite a new era for vaccines and vaccinology," he said. "We seemed to move ahead in this one year 10 years."These technologies had advanced enough that they were ready – in time for this year’s burst of COVID-19-related funding and attention – to be proved in human trials.It’s a silver lining of sorts to the pandemic. Without the urgency to find a solution to COVID-19, the money and the collaboration between government, academia and industry required for the breakthrough might not have come together for years, if ever."COVID is what made RNA jump to the head of the pack," said Dr. Drew Weissman, a professor of medicine at the University of Pennsylvania's Perelman School of Medicine. Though messenger RNA technology hasn't grabbed headlines before now, a handful of researchers, including Weissman, have been working on it for decades."Actually, it feels like my entire life," said Weissman, who helped launch and lead the field since the 1980s.Messenger RNAs are part of the body's toolkit – used to turn a DNA blueprint into the proteins needed for every cellular activity. Weissman and other researchers tried for years to get the technology to work, but every time they injected an experimental mRNA vaccine into an animal, it triggered dangerous inflammation. However, advances in the science – some credited to Weissman and his academic colleagues, others to government scientists or those in private industry – have finally brought mRNA vaccines to the finish line.The success serves as a reminder of the importance of basic science, said Dr. Barney Graham, a government researcher whose office has been collaborating with Moderna for nearly four years to advance their mRNA vaccine technology."Investment in basic science only helps," Graham said. "Even if it looks like some arcane idea that doesn't make sense, that kind of knowledge and basic understanding of biology and how things work are really informative to this kind of program." AstraZeneca: COVID-19 vaccine candidate developed by Oxford 'highly effective' in trials-The success of the companies' mRNA vaccines proves the technology is sound. Pfizer's completed trial of 44,000 people and Moderna's nearly finished trial of 30,000 found the approach to be safe, causing no major health issues, and effective, protecting more than 95% of those vaccinated."All the boxes have now been checked. The platform clearly works," Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said in a news conference announcing Moderna's effectiveness results. He said he would have been satisfied had the mRNA vaccines been 70%-75% effective."Our aspirations have been met, and that's really very good news," Fauci said. "Help is on the way."-How mRNA vaccines work and why they do so wellAdvocates say messenger RNA vaccines have several advantages over traditional technologies.They aren't grown in eggs or cells and don't have to go through the arduous purification of most vaccines, said Graham, deputy director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases."The more you can simplify things and just use exactly what you need and not anything more, overall it makes products safer and more likely to work," he said.The mRNA vaccines can be developed quickly.Moderna was ready to test its mRNA-1273 candidate vaccine in people about two months after receiving the genetic code of the virus from Chinese scientists. That's orders of magnitude faster than any vaccine ever before.Infected again or endless COVID-19? How the 'reinfection phenomenon' could impact vaccines, herd immunity and human behaviorIn clinical trials, the mRNA vaccines caused temporary side effects in 80%-90% of trial participants, but they were mild: Most had sore arms or felt cruddy for a day or two. No one fell seriously ill. Though that could change when vaccines are given to billions of people, the early results suggest bad reactions will be rare.Messenger RNA vaccines contain only a fraction of the virus, so unlike some vaccines, they can't give people the disease they're trying to prevent or trigger allergies to eggs or other traditional vaccine ingredients.Most of the COVID-19 vaccines under development introduce copies of the same "spike" protein found on the surface of the virus that causes COVID-19. They train the immune system to recognize this protein and attack in case of infection. The mRNA vaccines direct the machinery of human cells to manufacture that spike protein. The downside is mRNA molecules are fragile. To keep them from falling apart, researchers spent years figuring out how to encase the mRNAs in tiny droplets of fat.In Pfizer/BioNTech's vaccine, that fat has to stay at super-cold temperatures, so it maintains its shape and shields the mRNA.Moderna figured out how to maintain droplets for longer at warmer temperatures, so its vaccine needs to be stored at only normal freezing temperatures, or for up to a month in a fridge.The fat droplet boosts the effectiveness of the vaccine, turning more cells into spike-protein-producing machines, Weissman said, which may be why they proved so effective against COVID-19."I am incredibly enthusiastic about these results," he said.Messenger RNA past and promise-It took years of work for Weissman and a Penn colleague, Katalin Karikó, to find that if they swapped out one of the building blocks of RNA – called a nucleoside – not only would they solve their inflammation problem, the mRNA would make much more of the desired protein."We thought at that point it would be a great therapeutic," said Weissman, whose research is funded by BioNTech.Weissman and Karikó used their modified mRNA to make a hormone called erythropoietin, the absence of which causes a lack of red blood cells, leading to anemia. "It worked beautifully," Weissman said. So far, the results are confined to a lab dish, mice and macaque monkeys. Someday, he hopes to test similar approaches against diseases in people. In their lab, Weissman and his colleagues tested experimental vaccines against about 30 diseases. "It's looked great in just about all," he said.Experimental mRNA vaccines have protected mice and ferrets against all types of flu. They appeared effective against genital herpes and malaria. They produced proteins that have gone missing in a wide variety of diseases, such as cystic fibrosis.In addition to tackling COVID-19, Moderna has been developing mRNA vaccines against infectious diseases such as Zika and chikungunya, as well as others to fight cancer.Now that COVID-19 vaccines have proved the mRNA approach can work, there should be much more enthusiasm – and money – to pursue other mRNA vaccines and therapies."The potential is just enormous," Weissman said.a woman talking on a cell phone: Katelyn Evans, 16, gets the first of two shots as part of a trial testing of Pfizer's COVID-19 vaccine in minors. © Cincinnati Children's Hospital Katelyn Evans, 16, gets the first of two shots as part of a trial testing of Pfizer's COVID-19 vaccine in minors.Over the next few years, he and other scientists will work to reduce side effects from mRNA vaccines and therapies, while making them cheaper to manufacture, more stable at warmer temperatures and more potent – so they can hopefully be given in one dose, instead of the two shots needed against COVID-19. "My expectation is that those practical aspects, such as the temperature storage and stability over time at different temperatures, will continue to improve moving forward," said Dr. Dan Barouch, a professor of medicine at Harvard Medical School and director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, both in Boston.Barouch and others dream of a vaccine that could be dispatched within a few months of a new outbreak."This (pandemic) would have evolved very differently if we had been able to immunize back in March," noted Dr. Bruce Walker, who directs the Ragon Institute of MGH, MIT and Harvard, which focuses on immunology and vaccine development."As we get more experience with these vaccines and as we learn from this pandemic how to actually scale up rapidly," he said, "I think more and more time can be shaved off."A year ago, people would have said getting a vaccine developed and ready for the public within a year would be impossible. But two COVID-19 vaccines are likely to receive federal approval next month, and several more aren’t far behind."We've shown that's possible," Walker said. "And now we have to set our aspirations even higher."Contact Karen Weintraub at kweintraub@usatoday.com.Health and patient safety coverage at USA TODAY is made possible in part by a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation does not provide editorial input.This article originally appeared on USA TODAY: Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases.
Pfizer vs. Moderna COVID-19 vaccines - What's the difference? Over 50,000 doses of Pfizer’s COVID-19 vaccine have made it to the Badger State, this week alone.By: Julia Fello-8:00 AM, Dec 18, 2020
WAUWATOSA — Over 50,000 doses of Pfizer’s COVID-19 vaccine have made it to the Badger State, this week alone.With more vaccines possibly being approved down the pipeline, such as Moderna’s, a Doctor Mary Beth Graham, Infectious Disease Specialist at Froedtert and The Medical College of Wisconsin shares how each of the vaccines works in our bodies to protect us.“Is there a difference between the Pfizer vaccine and the Moderna vaccine?” asked TMJ4’s Julia Fello.Dr. Graham replied, “They’re basically the same type of vaccines.”Dr. Graham assures, “It cannot incorporate into your cell or change the DNA of your cell or mutate or do anything weird inside of you.”Dr. Graham says both the Pfizer and Moderna vaccines require two doses, “You will have your maximal antibody response and maximal immune response if you get the two-shot series. So the first shot, and the second shot in about three weeks.”Pfizer’s vaccine will be available to hospital workers and senior citizens living in assisted living centers first.CNBC reports Moderna’s vaccine could be approved by the FDA as early as Friday. The vaccine was backed by an expert panel Thursday afternoon.
